Sionna Therapeutics, Inc. 8-K

What Happened
Sionna Therapeutics, Inc. announced its financial results and business highlights for the fiscal year ended December 31, 2025 in a press release dated March 2, 2026. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8‑K (Item 2.02: Results of Operations and Financial Condition).

Key Details

• Press release announcing 2025 financial results and business highlights was issued on March 2, 2026.
• The results cover the fiscal year ended December 31, 2025.
• The press release is furnished as Exhibit 99.1 to the 8‑K (Item 9.01 also references the exhibit).
• The 8‑K indicates the company’s formal public disclosure of year‑end earnings information (Item 2.02).

Why It Matters
This 8‑K furnishes Sionna’s official year‑end update for 2025 — the primary source for investors to see the company’s reported financial performance and any business highlights or program updates for that year. Retail investors should read the March 2, 2026 press release (Exhibit 99.1) for the specific metrics — such as revenue, net loss, cash runway, and any guidance or clinical/program milestones — which can affect valuation, financing needs, and near‑term outlook.